Company name
2022Founder
BigHat Biosciences designs next-generation protein therapeutics with a closed-loop AI platform linking generative design to high-throughput experimentation, now advancing its first clinical program.
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.